-
1. Two-year Clinical Outcome in Patients with Small Coronary Artery Disease Treated with Everolimus- versus Paclitaxel-Eluting Stenting. J Cardiol. 2016;68(3):209-14.
Nasu K, Oikawa Y, et al.
-
2. Difference of vascular response between everolimus- and paclitaxel-eluting stents for small coronary artery disease: Optical coherence tomography analysis. Int J Cardiol Heart and Vessels 2014;3:21-27.
Nasu K, Oikawa Y, Aizawa T, Suzuki T.
-
3. Impact of Cholesterol Metabolism on Coronary Plaque Vulnerability of Target Vessels: A Combined Analysis of Virtual Histology Intravascular Ultrasound and Optical Coherence Tomography. JACC Cardiovasc Interv. 2013;6:746-55.
Nasu K, Terashima M, Habara M, Ko E, Ito T, Yokota D, Ishizuka S, Kurita T, Kinoshita Y, Kimura M, Asakura Y, Tsuchikane E, Katoh O, Suzuki T.
-
4. A randomized comparison of sirolimus- vs. paclitaxel-eluting stents for treatment of bifurcation lesions by single stent and kissing balloon: Results of the SINGLE KISS trial. Int J Cardiol. 2011 Nov 8. [Epub ahead of print]
Nasu K, Oikawa Y, Yoshikawa R, Kadotani M, Takeda Y, Ota H, Kamiya H, Muto M, Okamura A, Yamaki M, Usui S, Tohara S, Yamashita J, Suzuki M, Kawaguchi R, Kawajiri K, Nakatsu Y, Uchida Y, Kashima Y, Kawashima N, Ozaki T, Ogawa T, Aizawa T, Suzuki T; on behalf of SKT investigators.
-
5. Effect of Fluvastatin on progression of coronary atherosclerotic plaque evaluated by intravascular ultrasound Virtual Histology. JACC Cardiovasc Interv. 2009 Jul;2(7):689-96.
Nasu K, Tsuchikane E, Katoh O, Vince DG, Margolis PM, Virmani R, Surmely JF, Ehara M, Kinoshita Y, Fujita H, Kimura M, Asakura K, Asakura Y, Matsubara T, Terashima M, Suzuki T.
-
6. Impact of intramural thrombus in coronary arteries on the accuracy of tissue characterization by in vivo intravascular ultrasound radiofrequency data analysis. Am J Cardiol. 2008;101:1079-1083.
Nasu K, Tsuchikane E, Katoh O, Vince DG, Margolis PM, Virmani R, Surmely JF, Ehara M, Kinoshita Y, Fujita H, Kimura M, Asakura K, Asakura Y, Matsubara T, Terashima M, Suzuki T.
-
7. Plaque characterisation by Virtual Histology intravascular ultrasound analysis in patients with type 2 diabetes. Heart. 2008;94:429-433.
Nasu K, Tsuchikane E, Katoh O, Fujita H, Surmely JF, Ehara M, Kinoshita Y, Tanaka N, Matsubara T, Asakura Y, Asakura K, Terashima M, Suzuki T.
-
8. Accuracy of in vivo coronary plaque morphology assessment: a validation study of in vivo virtual histology compared with in vitro histopathology. J Am Coll Cardiol. 2006;47:2405-2412.
Nasu K, Tsuchikane E, Katoh O, Vince DG, Virmani R, Surmely JF, Murata A, Takeda Y, Ito T, Ehara M, Matsubara T, Terashima M, Suzuki T.
-
9. The safety and efficacy of "pre-closure" utilizing the Closer suture-mediated vascular closure device for achievement of hemostasis in patients following coronary interventions: results of the second Perclose Accelerated Ambulation and Discharge (PARADISE II) Trial. J Invasive Cardiol. 2005;17:30-33.
Nasu K, Tsuchikane E, Sumitsuji S, Tsuji T, Tamai H.
-
10. Quantitative angiographic and intravascular ultrasound study >5 years after directional coronary atherectomy. Am J Cardiol. 2004;93:543-548.
Nasu K, Tsuchikane E, Awata N, Matsumoto H, Shiota A, Takeda Y, Kobayashi T.
-
11. Clinical effectiveness of the Prostar XL suture-mediated percutaneous vascular closure device following PCI: results of the Perclose AcceleRated Ambulation and DISchargE (PARADISE) Trial. J Invasive Cardiol. 2003;15:251-256.
Nasu K, Tsuchikane E, Sumitsuji S; PARADISE Investigators.
-
12. In vivo tissue characterization of human atherosclerotic plaques by optical coherence tomography: A directional coronary atherectomy study with histopathologic confirmation. Int J Cardiol. 2018 Oct 1;268:1-10. doi: 10.1016/j.ijcard.2018.05.022. Epub 2018 May 10.
Habara M, Otsuka F, Tsuchikane E, Terashima M, Nasu K, Kinoshita Y, Murata A, Suzuki Y, Kawase Y, Okubo M, Matsuo H, Matsubara T, Yasuda S, Ishibashi-Ueda H, Suzuki T.
-
13. Novel proctorship effectively teaches interventionists coronary artery chronic total occlusion lesions. Cardiovasc Revasc Med. 2018 Jun;19(4):407-412. doi: 10.1016/j.carrev.2017.10.015. Epub 2017 Oct 26.
Yamamoto M, Tsuchikane E, Kagase A, Shimura T, Teramoto T, Kimura M, Matsuo H, Kawase Y, Suzuki Y, Kano S, Habara M, Nasu K, Kinoshita Y, Terashima M, Matsubara T, Suzuki T.
-
14. Impact of Serum Phosphorus Levels on Outcomes After Implantation of Drug-Eluting Stents in Patients on Hemodialysis. Circ J. 2018 Jan 25;82(2):388-395. doi: 10.1253/circj.CJ-17-0649. Epub 2017 Oct 20.
Sato T, Aoki J, Kozuma K, Maruyama Y, Nasu K, Otsuka M, Ando K, Hibi K, Uehara Y, Tanabe K, Ikari Y.
-
15. Initial results of a first-in-human study on the PlasmaWire™ System, a new radiofrequency wire for recanalization of chronic total occlusions. Catheter Cardiovasc Interv. 2018 May 1;91(6):1045-1051. doi: 10.1002/ccd.27333. Epub 2017 Oct 5
Kanno D, Tsuchikane E, Nasu K, Katoh O, Kashima Y, Kaneko U, Fujita T, Suzuki Y, Suzuki T.
-
16. Unprotected left main coronary artery bifurcation stenosis: impact of plaque debulking prior to single sirolimus-eluting stent implantation. J Invasive Cardiol. 2008;20:505-510.
Tanaka N, Terashima M, Kinoshita Y, Kimura M, Nasu K, Ehara M, Tsuchikane E, Matsubara T, Asakura Y, Katoh O, Suzuki T.
-
17. Diagnostic accuracy of coronary in-stent restenosis using 64-slice computed tomography: comparison with invasive coronary angiography. J Am Coll Cardiol. 2007;49:951-959.
Ehara M, Kawai M, Surmely JF, Matsubara T, Terashima M, Tsuchikane E, Kinoshita Y, Ito T, Takeda Y, Nasu K, Tanaka N, Murata A, Fujita H, Sato K, Kodama A, Katoh O, Suzuki T.
-
18. Coronary septal collaterals as an access for the retrograde approach in the percutaneous treatment of coronary chronic total occlusions. Catheter Cardiovasc Interv. 2007;69:826-832.
Surmely JF, Katoh O, Tsuchikane E, Nasu K, Suzuki T.
-
19. Association of coronary plaque composition and arterial remodelling: a virtual histology analysis by intravascular ultrasound. Heart. 2007;93:928-932.
Surmely JF, Nasu K, Fujita H, Terashima M, Matsubara T, Tsuchikane E, Ehara M, Kinoshita Y, Takeda Y, Tanaka N, Katoh O, Suzuki T.
-
20. Coronary plaque composition of culprit/target lesions according to the clinical presentation: a virtual histology intravascular ultrasound analysis. Eur Heart J. 2006;27:2939-2944.
Surmely JF, Nasu K, Fujita H, Terashima M, Matsubara T, Tsuchikane E, Ehara M, Kinoshita Y, Zheng QX, Tanaka N, Katoh O, Suzuki T.
-
21. Stent strut fracture-induced restenosis in a bifurcation lesion treated with the crush stenting technique. Circ J. 2006;70:936-938.
Surmely JF, Kinoshita Y, Dash D, Matsubara T, Terashima M, Ehara M, Ito T, Nasu K, Takeda Y, Tanaka N, Suzuki T, Katoh O.
-
22. Diagnostic accuracy of 64-slice computed tomography for detecting angiographically significant coronary artery stenosis in an unselected consecutive patient population: comparison with conventional invasive angiography. Circ J. 2006;70:564-571.
Ehara M, Surmely JF, Kawai M, Katoh O, Matsubara T, Terashima M, Tsuchikane E, Kinoshita Y, Suzuki T, Ito T, Takeda Y, Nasu K, Tanaka N, Murata A, Suzuki Y, Sato K, Suzuki T.
-
23. Balloon angioplasty plus cilostazol administration versus primary stenting of small coronary artery disease: final results of COMPASS. Catheter Cardiovasc Interv. 2004;63:44-51.
Tsuchikane E, Takeda Y, Nasu K, Awata N, Kobayashi T.
-
24. Effect of preintervention remodeling type on subsequent coronary artery behavior after directional atherectomy. Am J Cardiol. 2004;93:339-343.
Takeda Y, Tsuchikane E, Kobayashi T, Yachiku K, Nasu K, Awata N, Kobayashi T.
-
25. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Circ J. 2003;67:763-767.
Tsuchikane E, Takeda Y, Kobayashi T, Yachiku K, Nasu K, Kobayashi Y, Matsumoto H, Awata N.
-
26. Intravascular ultrasound measures of coronary atherosclerosis are associated with the Framingham risk score: an analysis from a global IVUS registry. EuroIntervention. 2009;5:212-8.
Marso SP, Frutkin AD, Mehta SK, House JA, McCrary JR, Klauss V, Lerman A, Leon MB, Nair A, Margolis P, Erbel R, Nasu K, Schiele F, Margolis J.
-
27. Rotational atherectomy for fibro-calcific coronary artery disease in drug eluting stent era: procedural outcomes and angiographic follow-up results. Catheter Cardiovasc Interv. 2010;75:919-27.
Rathore S, Matsuo H, Terashima M, Kinoshita Y, Kimura M, Tsuchikane E, Nasu K, Ehara M, Asakura Y, Katoh O, Suzuki T.
-
28. The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol. 2010 ;55:1590-7.
Kubo T, Maehara A, Mintz GS, Doi H, Tsujita K, Choi SY, Katoh O, Nasu K, Koenig A, Pieper M, Rogers JH, Wijns W, Böse D, Margolis MP, Moses JW, Stone GW, Leon MB.
-
29. Efficacy of biolimus A9-eluting stent for treatment of right coronary ostial lesion with intravascular ultrasound guidance: a multi-center registry. Cardiovasc Interv Ther. 2017 Sep 19. doi: 10.1007/s12928-017-0487-4. [Epub ahead of print]
Nasu K, Oikawa Y, Habara M, Shirai S, Abe H, Kadotani M, Gotoh R, Hozawa H, Ota H, Suzuki T, Shibata Y, Tanabe M, Nakagawa Y, Serikawa T, Nagasaka S, Takeuchi Y, Fujimoto Y, Tamura H, Kobori Y, Yajima J, Aizawa T, Suzuki T; NO-RECOIL Registries Investigators.
-
30. Initial results of a first-in-human study on the PlasmaWire™ System, a new radiofrequency wire for recanalization of chronic total occlusions. Catheter Cardiovasc Interv. 2017 Oct 5. doi: 10.1002/ccd.27333. [Epub ahead of print]
Kanno D, Tsuchikane E, Nasu K, Katoh O, Kashima Y, Kaneko U, Fujita T, Suzuki Y, Suzuki T.
-
ライブデモンストレーション術者
-
1. CTO Camp (2017.03.11) at Severance Hospital, Yonsei University, Korea
-
2. CIT 2017 (2017.04.01) at Fuwai Hospital, Beijing, Chaina
-
3. CTO Club (2017.06.02) at Higashitakarazuka Sato Hospital, Japan
-
4. Indo Japan CTO (IJCTO) live demonstration course (2017.06.10) at SGPGI, Mumbai, India
-
5. China Heart Conference (CHC) 2015 (2017.08.11) at Fuwai Hospital, China
-
6. CCT 2017 (2017.10.27) at Toyohashi Heart Center, Japan
-
7. IMC LIVE 2018 (2018.01.11) at IMC, Jeddah, Saudi Arabia
-
8. India Live 2018 (2018.03.01) at MMM, Chennai, India
-
9. CTO Camp (2018.03.03) at Severance Hospital, Yonsei University, Korea
-
10. CIT 2018 (2018.03.24) at Sir Run Run Shaw Hospital, Hangzhou, Chaina
-
11. TCT AP 2018 (2018.04.28) at Severance Hospital, Yonsei University, Korea
-
12. Indo Japan CTO (IJCTO) live demonstration course (2018.06.02) at Apollo Hospital, Hyderabad, India
-
13. CTO Club (2018.06.16) at Higashitakarazuka Sato Hospital, Japan
-
14. My Live (2018.07.27) at KL, Malaysia
-
15. China Heart Conference (CHC) 2018 (2018.08.04) at Fuwai Hospital, China
-
16. Euro CTO Club 2018 (2018.09.14) at Toulouse, France.
-
17. China CTO Club 2018 (2018.10.19) at Shanghai, China
-
18. CCT 2018 (2018.10.27) at Toyohashi Heart Center, Japan
-
19. CTO Camp (2019.2.23) at Severance Hospital, Yonsei University, Korea
-
20. India Live 2019 (2019.04.01) at Mumbai, India.
-
21. CIT 2019 (2019.03.30) at Fuwai Hp., China.
-
22. CTO Summit (2019.04.11) at Turin, Italy.
-
23. TCT AP 2019 (2019.04.30) at Severance Hospital, Yonsei University, Korea.
-
24. Kokura Live demonstration (2019.05.18) at Kokura Memorial Hospital, Japan.
-
25. Indo Japan CTO (IJCTO) live demonstration course (2019.06.01) at Mumbai, India
-
26. CTO Club (2019.06.15) at Otakanomori Hospital, Japan
-
27. ML CTO (2019.06.27) at Nice, Japan
-
28. TTT2020 (2020.1) at Taipei
-
29. CTO Club (20221.6) at Sakurabashi Watanabe Hospital, Japan
-
30. CCT 2021 (2021.10) at Toyohashi Heart Center
-
31. CTO Club (2022.6) at Otakanomori Hospital, Japan
-
32. Euro CTO Club 2022 (22022.9) at MIntz, Germany.
-
33. CCT 2022 (2022.10) at Mie and Toyohashi Heart Center
-
34. CTO Club (2023.6) at Cardiovascular Institute Hospital, Japan
-
35. CCT 2023 (2023.10) at Cardiovascular Institute Hospital, Japan
